GlassScriptOtosight Middle Ear Scope
Payments companies reported to CMS as associated with Otosight Middle Ear Scope. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Otosight Middle Ear Scope, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Otosight Middle Ear Scope
These are the largest totals companies reported as associated with Otosight Middle Ear Scope. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Keith Matheny | Frisco, TX | Otolaryngology | $15,243.22 |
| Raza Pasha | Houston, TX | Otolaryngology | $5,872.41 |
| Philip Matorin | Houston, TX | Otolaryngology | $5,872.41 |
| Hector Ubaldo | Katy, TX | Internal Medicine | $4,933.59 |
| Haider Afzal | Baytown, TX | Family Medicine | $4,661.40 |
| David Maynoldi | Orange Park, FL | Hospitalist | $3,531.25 |
| Elizabeth Newman | Lake City, FL | Primary Care | $2,295.49 |
| Leanna Stebbins | Lake City, FL | Family | $2,274.91 |
| Milady Mortimer-Oragwu | Humble, TX | Family | $2,083.37 |
| Chukwuemeka Oragwu | Humble, TX | Family Medicine | $2,083.37 |
Prescribed Otosight Middle Ear Scope?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.